National HealthCare Resultados de beneficios anteriores

Pasado controles de criterios 3/6

National HealthCarehan disminuido a un ritmo medio anual de -4.6%, mientras que en la industria Healthcare los ingresos han sido de growing a 9% anuales. Los ingresos han sido growing a un ritmo medio de 2.4% al año. National HealthCare La rentabilidad de los fondos propios de la empresa es de 4.8% y sus márgenes netos son de 4.1%.

Información clave

-5.0%

Tasa de crecimiento de los beneficios

-5.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.5%
Tasa de crecimiento de los ingresos	2.8%
Rentabilidad financiera	7.2%
Margen neto	5.9%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

May 01

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Apr 09

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?

Mar 17

National HealthCare Corporation's (NYSEMKT:NHC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Mar 02

National HealthCare Corporation (NYSEMKT:NHC) Insiders Have Been Selling

Feb 15

Reflecting on National HealthCare's (NYSEMKT:NHC) Share Price Returns Over The Last Year

Feb 02

Could The National HealthCare Corporation (NYSEMKT:NHC) Ownership Structure Tell Us Something Useful?

Jan 20

These Metrics Don't Make National HealthCare (NYSEMKT:NHC) Look Too Strong

Jan 07

Do These 3 Checks Before Buying National HealthCare Corporation (NYSEMKT:NHC) For Its Upcoming Dividend

Dec 25

What We Learned About National HealthCare's (NYSEMKT:NHC) CEO Pay

Dec 24

Is National HealthCare Corporation's (NYSEMKT:NHC) 3.1% Dividend Worth Your Time?

Dec 12

Does National HealthCare Corporation's (NYSEMKT:NHC) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Nov 30

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero National HealthCare. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSEAM:NHC Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	1,135	67	42
30 Sep 23	1,105	45	40
30 Jun 23	1,087	32	40
31 Mar 23	1,075	19	41
31 Dec 22	1,074	22	41
30 Sep 22	1,079	32	41
30 Jun 22	1,074	31	41
31 Mar 22	1,051	133	41
31 Dec 21	1,011	139	41
30 Sep 21	989	150	40
30 Jun 21	961	167	40
31 Mar 21	950	90	40
31 Dec 20	978	42	40
30 Sep 20	985	28	41
30 Jun 20	994	35	41
31 Mar 20	1,004	20	41
31 Dec 19	996	68	41
30 Sep 19	990	73	41
30 Jun 19	989	74	41
31 Mar 19	984	83	41
31 Dec 18	979	59	41
30 Sep 18	977	62	41
30 Jun 18	972	52	41
31 Mar 18	968	41	41
31 Dec 17	964	56	40
30 Sep 17	956	49	41
30 Jun 17	947	48	41
31 Mar 17	936	50	41
31 Dec 16	924	51	41
30 Sep 16	923	51	41
30 Jun 16	917	51	41
31 Mar 16	914	49	40
31 Dec 15	907	46	40
30 Sep 15	899	44	40
30 Jun 15	892	45	40
31 Mar 15	884	45	40
31 Dec 14	872	45	40
30 Sep 14	852	46	40
30 Jun 14	830	54	40
31 Mar 14	805	55	39
31 Dec 13	789	56	39
30 Sep 13	773	55	39
30 Jun 13	767	53	39

Ingresos de calidad: NHC tiene un gran one-off gain de $20.5M impacto en sus últimos 12 meses de resultados financieros a 31st December, 2023.

Margen de beneficios creciente: NHCLos actuales márgenes de beneficio netos de (4.1%) son superiores a los del año pasado (3%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: NHCLos beneficios de la empresa han disminuido en 4.6% al año en los últimos 5 años.

Acelerando crecimiento: NHCEl crecimiento de los beneficios de la empresa en el último año (40.4%) supera su media de 5 años (-4.6% al año).

Beneficios vs. Industria: NHC El crecimiento de los beneficios en el último año (40.4%) superó al del sector Healthcare 0.3% .

Rentabilidad financiera

Alta ROE: El Retorno sobre el capital de NHC (4.8%) se considera bajo.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

National HealthCare Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings released: EPS: US$4.36 (vs US$1.46 in FY 2022)

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.16 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$1.06 (vs US$0.21 in 2Q 2022)

First quarter 2023 earnings released: EPS: US$0.76 (vs US$0.99 in 1Q 2022)

Full year 2022 earnings released: EPS: US$1.46 (vs US$9.03 in FY 2021)

Third quarter 2022 earnings released: US$0.16 loss per share (vs US$0.22 loss in 3Q 2021)

Recent updates

National HealthCare Corporation, Annual General Meeting, May 09, 2024

Upcoming dividend of US$0.59 per share

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$4.36 (vs US$1.46 in FY 2022)

Third quarter dividend of US$0.59 announced

NHC Announces Quarterly Common Dividend, Payable on May 1, 2024

Independent Director exercised options to buy US$312k worth of stock.

Upcoming dividend of US$0.59 per share at 2.5% yield

Independent Chairman exercised options to buy US$290k worth of stock.

Independent Director recently sold US$641k worth of stock

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.16 loss in 3Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on February 1, 2024

Independent Director exercised options to buy US$131k worth of stock.

Upcoming dividend of US$0.59 per share at 3.5% yield

Independent Chairman recently bought US$131k worth of stock

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: EPS: US$1.06 (vs US$0.21 in 2Q 2022)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2023

Independent Director recently bought US$129k worth of stock

Upcoming dividend of US$0.59 per share at 3.9% yield

Independent Director recently bought US$135k worth of stock

National HealthCare Corporation Announces Quarterly Dividend, Payable on July 31, 2023

First quarter 2023 earnings released: EPS: US$0.76 (vs US$0.99 in 1Q 2022)

Upcoming dividend of US$0.57 per share at 4.1% yield

Independent Director recently bought US$125k worth of stock

Full year 2022 earnings released: EPS: US$1.46 (vs US$9.03 in FY 2021)

National Healthcare Corporation Declares Quarterly Dividend, Payable on May 1, 2023

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$106k worth of stock.

Independent Director recently sold US$211k worth of stock

Insufficient new directors

National HealthCare Corporation Announces Quarterly Dividend, Payable on February 1, 2023

Third quarter 2022 earnings released: US$0.16 loss per share (vs US$0.22 loss in 3Q 2021)

Upcoming dividend of US$0.57 per share

Independent Director exercised options to buy US$175k worth of stock.

National HealthCare Corporation (NYSEAM:NHC) announces an Equity Buyback for $25 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$0.21 (vs US$6.83 in 2Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on November 1, 2022

Upcoming dividend of US$0.57 per share

Independent Chairman exercised options to buy US$135k worth of stock.

Independent Director exercised options to buy US$529k worth of stock.

First quarter 2022 earnings released: EPS: US$0.99 (vs US$1.39 in 1Q 2021)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 1, 2022

Insufficient new directors

Upcoming dividend of US$0.55 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

National Healthcare Corporation Announces Quarterly Dividend, Payable on May 2, 2022

National HealthCare Corporation Appoints Sandra Y. Trail to Its Board of Director, Effective February 1, 2022

Independent Director exercised options to buy US$350k worth of stock.

Upcoming dividend of US$0.55 per share

CEO & Director exercised options and sold US$132k worth of stock

Third quarter 2021 earnings released: US$0.22 loss per share (vs US$0.84 profit in 3Q 2020)

Upcoming dividend of US$0.52 per share

Second quarter 2021 earnings released: EPS US$6.83 (vs US$1.85 in 2Q 2020)

Upcoming dividend of US$0.52 per share

Independent Director exercised options to buy US$567k worth of stock.

First quarter 2021 earnings released: EPS US$1.39 (vs US$1.76 loss in 1Q 2020)

National Healthcare Corporation Announces Quarterly Dividend, Payable on August 2, 2021

Independent Director exercised options to buy US$527k worth of stock.

Why We Think National HealthCare Corporation's (NYSEMKT:NHC) CEO Compensation Is Not Excessive At All

Returns On Capital At National HealthCare (NYSEMKT:NHC) Paint A Concerning Picture

Upcoming Dividend of US$0.52 Per Share

Independent Director recently sold US$151k worth of stock

Is National HealthCare Corporation (NYSEMKT:NHC) A Good Fit For Your Dividend Portfolio?

Chairman of the Board exercised options to buy US$210k worth of stock.

New 90-day high: US$74.27

National HealthCare Corporation's (NYSEMKT:NHC) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Full year 2020 earnings released: EPS US$2.74 (vs US$4.47 in FY 2019)

National HealthCare Corporation (NYSEMKT:NHC) Insiders Have Been Selling

Desglose de ingresos y gastos
Beta